Cited by 800Extracellular vesicles in diseaseMicroRNA in disease regulationNanoparticle-Based Drug Delivery

Effect of exosomal miRNA on cancer biology and clinical applications

Open access
Sun, Zhenqiang, Shi, Ke, Yang, Shuaixi, Liu, Jinbo, Zhou, Quanbo, Wang, Guixian, Song, Junmin, Li, Zhen +2 more·2018·Molecular Cancer

Abstract

Exosomes, extracellular vesicles with diameters ranging from 30 to 150 nm, are widely present in various body fluids. Recently, microRNAs (miRNAs) have been identified in exosomes, the biogenesis, release, and uptake of which may involve the endosomal sorting complex required for transport (ESCRT complex) and relevant proteins. After release, exosomes are taken up by neighboring or distant cells, and the miRNAs contained within modulate such processes as interfering with tumor immunity and the microenvironment, possibly facilitating tumor growth, invasion, metastasis, angiogenesis and drug resistance. Therefore, exosomal miRNAs have a significant function in regulating cancer progression. Here, we briefly review recent findings regarding tumor-derived exosomes, including RNA sorting and delivering mechanism. We then describe the intercommunication occurring between different cells via exosomal miRNAs in tumor microenvironmnt, with impacts on tumor proliferation, vascularization, metastasis and other biological characteristics. Finally, we highlight the potential role of these molecules as biomarkers in cancer diagnosis and prognosis and tumor resistance to therapeutics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12943-018-0897-7

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 145

  1. [1]Scott AM Wolchok JD Old LJ Antibody therapy of cancer Nat Rev Cancer 2012 12 278 10.1038/nrc3236 22437872 · DOI
  2. [2]Behera J Tyagi N Exosomes: mediators of bone diseases, protection, and therapeutics potential Oncoscience 2018 5 181 195 30035185 PMC6049320
  3. [3]Carney R, Hazari S, Rojalin T, Knudson A, Gao T, Tang Y, Liu R, Viitala T, Yliperttula M, Lam K. Targeting Tumor-Associated Exosomes with Integrin-Binding Peptides. Adv Biosyst. 2017;1:1600038. PMC6001286 29911169
  4. [5]Mao Liang Li Xue Gong Shu Yuan Haiyang Jiang Yu Huang Wenjun Sun Xingwang Dang Xitong Serum exosomes contain ECRG4 mRNA that suppresses tumor growth via inhibition of genes involved in inflammation, cell proliferation, and angiogenesis Cancer Gene Therapy 2018 25 9-10 248 259 10.1038/s41417-018-0032-3 29983418 · DOI
  5. [6]Chaput N Thery C Exosomes: immune properties and potential clinical implementations Semin Immunopathol 2011 33 419 440 10.1007/s00281-010-0233-9 21174094 · DOI
  6. [7]Chiarugi P Cirri P Metabolic exchanges within tumor microenvironment Cancer Lett 2016 380 272 280 10.1016/j.canlet.2015.10.027 26546872 · DOI
  7. [8]Kahlert C Kalluri R Exosomes in tumor microenvironment influence cancer progression and metastasis Journal of Molecular Medicine-Jmm 2013 91 431 437 10.1007/s00109-013-1020-6 PMC4073669 23519402 · DOI
  8. [9]Benmoussa A Ly S Shan S Laugier J Boilard E Gilbert C Provost P A subset of extracellular vesicles carries the bulk of microRNAs in commercial dairy cow's milk J Extracell Vesicles 2017 6 1401897 10.1080/20013078.2017.1401897 29904572 PMC5994974 · DOI
  9. [10]Tkach M Thery C Communication by extracellular vesicles: where we are and where we need to go Cell 2016 164 1226 1232 10.1016/j.cell.2016.01.043 26967288 · DOI · Paper page
  10. [11]Sanz-Rubio D Martin-Burriel I Gil A Cubero P Forner M Khalyfa A Marin JM Stability of circulating Exosomal miRNAs in healthy subjects Sci Rep 2018 8 10 10.1038/s41598-018-28748-5 29985466 PMC6037782 · DOI
  11. [12]Hannafon BN Ding WQ Intercellular communication by exosome-derived microRNAs in Cancer Int J Mol Sci 2013 14 14240 14269 10.3390/ijms140714240 23839094 PMC3742242 · DOI
  12. [13]Ramachandran S Palanisamy V Horizontal transfer of RNAs: exosomes as mediators of intercellular communication Wiley Interdisciplinary Reviews-Rna 2012 3 286 293 10.1002/wrna.115 22012863 PMC3263325 · DOI
  13. [14]Lee Y El Andaloussi S Wood MJA Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy Hum Mol Genet 2012 21 R125 R134 10.1093/hmg/dds317 22872698 · DOI
  14. [15]Tamai K Tanaka N Nakano T Kakazu E Kondo Y Inoue J Shiina M Fukushima K Hoshino T Sano K Exosome secretion of dendritic cells is regulated by Hrs, an ESCRT-0 protein Biochem Biophys Res Commun 2010 399 384 390 10.1016/j.bbrc.2010.07.083 20673754 · DOI
  15. [16]Wollert T Hurley JH Molecular mechanism of multivesicular body biogenesis by ESCRT complexes Nature 2010 464 864 U873 10.1038/nature08849 20305637 PMC2851844 · DOI · Paper page
  16. [17]Tran N Cancer exosomes as miRNA factories Trends in Cancer 2016 2 329 331 10.1016/j.trecan.2016.05.008 28741535 · DOI
  17. [18]Qu L Ding J Chen C Wu ZJ Liu B Gao Y Chen W Liu F Sun W Li XF Exosome-transmitted lncARSR promotes Sunitinib resistance in renal Cancer by acting as a competing endogenous RNA Cancer Cell 2016 29 653 668 10.1016/j.ccell.2016.03.004 27117758 · DOI
  18. [19]Schickel R Boyerinas B Park SM Peter ME MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death Oncogene 2008 27 5959 5974 10.1038/onc.2008.274 18836476 · DOI
  19. [20]Zhang J Li S Li L Li M Guo CY Yao J Mi SL Exosome and Exosomal MicroRNA: trafficking, sorting, and function Genomics Proteomics & Bioinformatics 2015 13 17 24 10.1016/j.gpb.2015.02.001 PMC4411500 25724326 · DOI
  20. [21]Ostrowski M Carmo N Krumeich S Fanget I Raposo G Savina A Moita C Schauer K Hume A Freitas R Rab27a and Rab27b control different steps of the exosome secretion pathway Nat Cell Biol 2010 12 19 30 10.1038/ncb2000 19966785 · DOI
  21. [22]Yu X Harris S Levine A The regulation of exosome secretion: a novel function of the p53 protein Cancer Res 2006 66 4795 4801 10.1158/0008-5472.CAN-05-4579 16651434 · DOI
  22. [23]Wang YM Xu XY Yu SX Jeong KJ Zhou ZC Han L Tsang YH Li J Chen H Mangala LS Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers Genome Res 2017 27 1112 1125 10.1101/gr.219741.116 28411194 PMC5495064 · DOI
  23. [25]Klemm F Joyce JA Microenvironmental regulation of therapeutic response in cancer Trends Cell Biol 2015 25 198 213 10.1016/j.tcb.2014.11.006 25540894 PMC5424264 · DOI
  24. [26]Challagundla KB Fanini F Vannini I Wise P Murtadha M Malinconico L Cimmino A Fabbri M microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics Expert Rev Mol Diagn 2014 14 565 574 10.1586/14737159.2014.922879 24844135 · DOI
  25. [27]Lujambio A Lowe SW The microcosmos of cancer Nature 2012 482 347 355 10.1038/nature10888 22337054 PMC3509753 · DOI · Paper page
  26. [29]Taddei ML Giannoni E Comito G Chiarugi P Microenvironment and tumor cell plasticity: an easy way out Cancer Lett 2013 341 80 96 10.1016/j.canlet.2013.01.042 23376253 · DOI
  27. [30]Zhang ZC Li X Sun W Yue SQ Yang JY Li JJ Ma B Wang JL Yang XS Pu M Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis Cancer Lett 2017 397 33 42 10.1016/j.canlet.2017.03.004 28288874 · DOI
  28. [31]Du YE Tu G Yang GL Li GY Yang D Lang L Xi L Sun KX Chen YL Shu KX MiR-205/YAP1 in activated fibroblasts of breast tumor promotes VEGF-independent angiogenesis through STAT3 signaling Theranostics 2017 7 3972 3988 10.7150/thno.18990 29109792 PMC5667419 · DOI
  29. [32]Kohlhapp FJ Mitra AK Lengyel E Peter ME MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment Oncogene 2015 34 5857 5868 10.1038/onc.2015.89 25867073 PMC4604012 · DOI
  30. [33]Pang WJ Su JJ Wang YL Feng H Dai X Yuan YZ Chen X Yao WY Pancreatic cancer-secreted miR-155 implicates in the conversion from normal fibroblasts to cancer-associated fibroblasts Cancer Sci 2015 106 1362 1369 10.1111/cas.12747 26195069 PMC4638007 · DOI
  31. [34]Fang T Lv H Lv G Li T Wang C Han Q Yu L Su B Guo L Huang S Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer Nat Commun 2018 9 191 10.1038/s41467-017-02583-0 29335551 PMC5768693 · DOI · Paper page
  32. [35]Greening DW Gopal SK Xu R Simpson RJ Chen WS Exosomes and their roles in immune regulation and cancer Semin Cell Dev Biol 2015 40 72 81 10.1016/j.semcdb.2015.02.009 25724562 · DOI
  33. [36]Que RS Lin C Ding GP Wu ZR Cao LP Increasing the immune activity of exosomes: the effect of miRNA-depleted exosome proteins on activating dendritic cell/cytokine-induced killer cells against pancreatic cancer Journal of Zhejiang University-Science B 2016 17 352 360 10.1631/jzus.B1500305 27143262 PMC4868825 · DOI
  34. [37]Anastasiadou E Slack FJ Malicious exosomes Science 2014 346 1459 10.1126/science.aaa4024 25525233 · DOI
  35. [38]Venereau E, Ceriotti C, Bianchi ME. DAMPs from cell death to new life. Front Immunol. 2015;6. PMC4539554 26347745
  36. [39]Thwe PM Amiel E The role of nitric oxide in metabolic regulation of dendritic cell immune function Cancer Lett 2018 412 236 242 10.1016/j.canlet.2017.10.032 29107106 PMC5699934 · DOI
  37. [40]Hammer GE, Ma A: Molecular control of steady-state dendritic cell maturation and immune homeostasis. IN Annual Review of Immunology, Vol 31. Volume 31. Edited by Littman DR, Yokoyama WM 2013: 743–791: Annual Review of Immunology]. PMC4091962 23330953
  38. [41]Fabbri M Paone A Calore F Galli R Gaudio E Santhanam R Lovat F Fadda P Mao C Nuovo GJ MicroRNAs bind to toll-like receptors to induce prometastatic inflammatory response Proc Natl Acad Sci U S A 2012 109 E2110 E2116 10.1073/pnas.1209414109 22753494 PMC3412003 · DOI
  39. [42]Greither T Grochola LF Udelnow A Lautenschlager C Wurl P Taubert H Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival Int J Cancer 2010 126 73 80 10.1002/ijc.24687 19551852 · DOI
  40. [43]Berzins SP Ritchie DS Natural killer T cells: drivers or passengers in preventing human disease? Nat Rev Immunol 2014 14 640 646 10.1038/nri3725 25103356 · DOI
  41. [44]Donatelli SS Zhou JM Gilvary DL Eksioglu EA Chen XH Cress WD Haura EB Schabath MB Coppola D Wei S Djeu JY TGF-beta-inducible microRNA-183 silences tumor-associated natural killer cells Proc Natl Acad Sci U S A 2014 111 4203 4208 10.1073/pnas.1319269111 24586048 PMC3964044 · DOI
  42. [45]Noman MZ Buart S Romero P Ketari S Janji B Mari B Mami-Chouaib F Chouaib S Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells Cancer Res 2012 72 4629 4641 10.1158/0008-5472.CAN-12-1383 22962263 · DOI
  43. [46]Feitelson MA Arzumanyan A Kulathinal RJ Blain SW Holcombe RF Mahajna J Marino M Martinez-Chantar ML Nawroth R Sanchez-Garcia I Sustained proliferation in cancer: mechanisms and novel therapeutic targets Semin Cancer Biol 2015 35 S25 S54 10.1016/j.semcancer.2015.02.006 25892662 PMC4898971 · DOI
  44. [47]Kogure T Lin W-L Yan IK Braconi C Patel T Inter-cellular nanovesicle mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth Hepatology (Baltimore, Md) 2011 54 1237 1248 10.1002/hep.24504 PMC3310362 21721029 · DOI · Paper page
  45. [48]Kim J Morley S Le M Bedoret D Umetsu DT Di Vizio D Freeman MR Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells potential effects on the tumor microenvironment Cancer Biology & Therapy 2014 15 409 418 10.4161/cbt.27627 24423651 PMC3979818 · DOI
  46. [49]Mo Li-Jun Song Man Huang Qiao-Hua Guan Hua Liu Xiao-Dan Xie Da-Fei Huang Bo Huang Rui-Xue Zhou Ping-Kun Exosome-packaged miR-1246 contributes to bystander DNA damage by targeting LIG4 British Journal of Cancer 2018 119 4 492 502 10.1038/s41416-018-0192-9 30038324 PMC6134031 · DOI
  47. [50]Zhang L Zhan SY Yao J Lowery FJ Zhang QL Huang WC Li P Li M Wang X Zhang CY Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth Nature 2015 527 100 104 10.1038/nature15376 26479035 PMC4819404 · DOI · Paper page
  48. [51]Liang XL Zhang LN Wang SH Han Q Zhao RC Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a J Cell Sci 2016 129 2182 2189 10.1242/jcs.170373 27252357 · DOI
  49. [52]Cui H Seubert B Stahl E Dietz H Reuning U Moreno-Leon L Ilie M Hofman P Nagase H Mari B Kruger A Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes Oncogene 2015 34 3640 3650 10.1038/onc.2014.300 25263437 · DOI
  50. [53]Liu Y Luo F Wang BR Li HQ Xu Y Liu XL Shi L Lu XL Xu WC Lu L STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells Cancer Lett 2016 370 125 135 10.1016/j.canlet.2015.10.011 26525579 · DOI
  51. [54]Hood JL Roman SS Wickline SA Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis Cancer Res 2011 71 3792 3801 10.1158/0008-5472.CAN-10-4455 21478294 · DOI
  52. [55]Gomes FG Nedel F Alves AM Nor JE Tarquinio SBC Tumor angiogenesis and lymphangiogenesis: tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanisms Life Sci 2013 92 101 107 10.1016/j.lfs.2012.10.008 23178150 PMC3740377 · DOI
  53. [56]Salido-Guadarrama I Romero-Cordoba S Peralta-Zaragoza O Hidalgo-Miranda A Rodriguez-Dorantes M MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer Oncotargets and Therapy 2014 7 1327 1338 25092989 PMC4114916
  54. [57]Yu SR Cao HX Shen B Feng JF Tumor-derived exosomes in cancer progression and treatment failure Oncotarget 2015 6 37151 37168 26452221 PMC4741921
  55. [59]Shah MY Calin GA The mix of two worlds: non-coding RNAs and hormones Nucleic Acid Therapeutics 2013 23 2 8 10.1089/nat.2012.0375 23051203 PMC3569955 · DOI
  56. [60]Uen Y Wang J Wang C Jhang Y Chung J Tseng T Sheu M Lee S Mining of potential microRNAs with clinical correlation - regulation of syndecan-1 expression by miR-122-5p altered mobility of breast cancer cells and possible correlation with liver injury Oncotarget 2018 9 28165 28175 10.18632/oncotarget.25589 29963269 PMC6021336 · DOI
  57. [61]Wang C Gu S Cao H Li Z Xiang Z Hu K Han X miR-877-3p targets Smad7 and is associated with myofibroblast differentiation and bleomycin-induced lung fibrosis Sci Rep 2016 6 30122 10.1038/srep30122 27444321 PMC4957095 · DOI
  58. [62]Nanbo A Katano H Kataoka M Hoshina S Sekizuka T Kuroda M Ohba Y Infection of Epstein–Barr virus in type III latency modulates biogenesis of exosomes and the expression profile of Exosomal miRNAs in the Burkitt lymphoma Mutu cell lines Cancers 2018 10 237 10.3390/cancers10070237 PMC6071279 30029522 · DOI
  59. [63]Konstatinell A, Coucheron D, Sveinbjørnsson B, Moens U. MicroRNAs as Potential Biomarkers in Merkel Cell Carcinoma. Int J Mol Sci. 2018;19:3119-31. PMC6073391 29949882
  60. [64]Zhao L Liu WT Xiao J Cao BW The role of exosomes and “exosomal shuttle microRNA” in tumorigenesis and drug resistance Cancer Lett 2015 356 339 346 10.1016/j.canlet.2014.10.027 25449429 · DOI
  61. [65]Takahashi R Prieto-Vila M Kohama I Ochiya T MicroRNA in body fluids - development of the novel plat form for Cancer therapeutics and diagnosis Gan To Kagaku Ryoho 2018 45 899 905 30026410
  62. [66]Corcoran Claire Rani Sweta O’Brien Keith O’Neill Amanda Prencipe Maria Sheikh Rizwan Webb Glenn McDermott Ray Watson William Crown John O’Driscoll Lorraine Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes PLoS ONE 2012 7 12 e50999 10.1371/journal.pone.0050999 23251413 PMC3519481 · DOI
  63. [67]Corcoran C Rani S O'Driscoll L miR-34a is an intracellular and Exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate Cancer progression Prostate 2014 74 1320 1334 10.1002/pros.22848 25053345 · DOI
  64. [68]Wei YF Lai XF Yu ST Chen SN Ma YZ Zhang Y Li HC Zhu XM Yao LB Zhang J Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells Breast Cancer Res Treat 2014 147 423 431 10.1007/s10549-014-3037-0 25007959 · DOI
  65. [69]Li B Ren S Li X Wang Y Garfield D Zhou S Chen X Su C Chen M Kuang P MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer Lung Cancer 2014 83 146 153 10.1016/j.lungcan.2013.11.003 24331411 · DOI
  66. [70]Ma Y Xia H Liu Y Li M Silencing miR-21 sensitizes non-small cell lung cancer A549 cells to ionizing radiation through inhibition of PI3K/Akt Biomed Res Int 2014 2014 617868 24804226 PMC3997135
  67. [71]Bica-Pop Cecilia Cojocneanu-Petric Roxana Magdo Lorand Raduly Lajos Gulei Diana Berindan-Neagoe Ioana Overview upon miR-21 in lung cancer: focus on NSCLC Cellular and Molecular Life Sciences 2018 75 19 3539 3551 10.1007/s00018-018-2877-x 30030592 PMC11105782 · DOI
  68. [72]Schwarzenbach H Clinical relevance of circulating, cell-free and Exosomal microRNAs in plasma and serum of breast Cancer patients Oncology Research and Treatment 2017 40 423 429 10.1159/000478019 28683441 · DOI
  69. [73]Rotelli MT Di Lena M Cavallini A Lippolis C Bonfrate L Chetta N Portincasa P Altomare DF Fecal microRNA profile in patients with colorectal carcinoma before and after curative surgery Int J Color Dis 2015 30 891 898 10.1007/s00384-015-2248-0 25989926 · DOI
  70. [74]Eichelser C Stückrath I Müller V Milde-Langosch K Wikman H Pantel K Schwarzenbach H Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients Oncotarget 2014 5 9650 9663 10.18632/oncotarget.2520 25333260 PMC4259427 · DOI
  71. [75]Huang XY Yuan TZ Liang MH Du MJ Xia S Dittmar R Wang D See W Costello BA Quevedo F Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate Cancer Eur Urol 2015 67 33 41 10.1016/j.eururo.2014.07.035 25129854 PMC4252606 · DOI
  72. [76]Matsumura T Sugimachi K Iinuma H Takahashi Y Kurashige J Sawada G Ueda M Uchi R Ueo H Takano Y Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer Br J Cancer 2015 113 275 281 10.1038/bjc.2015.201 26057451 PMC4506387 · DOI
  73. [77]Aucher A Rudnicka D Davis DM MicroRNAs transfer from human macrophages to Hepato-carcinoma cells and inhibit proliferation J Immunol 2013 191 6250 6260 10.4049/jimmunol.1301728 24227773 PMC3858238 · DOI · Paper page
  74. [78]Xu XD Wu XH Fan YR Tan B Quan Z Luo CL Exosome-derived microRNA-29c induces apoptosis of BIU-87 cells by down regulating BCL-2 and MCL-1 Asian Pac J Cancer Prev 2014 15 3471 3476 10.7314/APJCP.2014.15.8.3471 24870742 · DOI
  75. [79]Lim PK Bliss SA Patel SA Taborga M Dave MA Gregory LA Greco SJ Bryan M Patel PS Rameshwar P Gap junction-mediated import of MicroRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast Cancer cells Cancer Res 2011 71 1550 1560 10.1158/0008-5472.CAN-10-2372 21343399 · DOI
  76. [80]Ge L Sun X Hong Q Li F Ratiometric NanoCluster Beacon: a label-free and sensitive fluorescent DNA detection platform ACS Appl Mater Interfaces 2017 9 13102 13110 10.1021/acsami.7b03198 28367619 · DOI
  77. [81]Xia Y Wang L Li J Chen X Lan J Yan A Lei Y Yang S Yang H Chen J A Ratiometric fluorescent bioprobe based on carbon dots and Acridone derivate for signal amplification detection Exosomal microRNA Anal Chem 2018 90 8969 8976 10.1021/acs.analchem.8b01143 29973048 · DOI
  78. [83]Syn NL Wang LZ Chow EKH Lim CT Goh BC Exosomes in Cancer nanomedicine and immunotherapy: prospects and challenges Trends Biotechnol 2017 35 665 676 10.1016/j.tibtech.2017.03.004 28365132 · DOI
  79. [84]Barile L Vassalli G Exosomes: therapy delivery tools and biomarkers of diseases Pharmacol Ther 2017 174 63 78 10.1016/j.pharmthera.2017.02.020 28202367 · DOI
  80. [85]Shao YK Shen YW Chen T Xu F Chen XW Zheng S The functions and clinical applications of tumor-derived exosomes Oncotarget 2016 7 60736 60751 27517627 PMC5312416
  81. [86]Yu DD Wu Y Shen HY Lv MM Chen WX Zhang XH Zhong SL Tang JH Zhao JH Exosomes in development, metastasis and drug resistance of breast cancer Cancer Sci 2015 106 959 964 10.1111/cas.12715 26052865 PMC4556383 · DOI
  82. [87]He CJ Zheng S Luo Y Wang B Exosome Theranostics: biology and translational medicine Theranostics 2018 8 237 255 10.7150/thno.21945 29290805 PMC5743472 · DOI
  83. [88]Shimbo K Miyaki S Ishitobi H Kato Y Kubo T Shimose S Ochi M Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration Biochem Biophys Res Commun 2014 445 381 387 10.1016/j.bbrc.2014.02.007 24525123 · DOI
  84. [89]Assmann TS, Recamonde-Mendoza M, de Souza BM, Bauer AC, Crispim D. MicroRNAs and diabetic kidney disease: Systematic review and bioinformatic analysis. Mol Cell Endocrinol. 2018;477:90-102. 29902497
  85. [90]Chevillet JR Kang Q Ruf IK Briggs HA Vojtech LN Hughes SM Cheng HH Arroyo JD Meredith EK Gallichotte EN Quantitative and stoichiometric analysis of the microRNA content of exosomes Proc Natl Acad Sci U S A 2014 111 14888 14893 10.1073/pnas.1408301111 25267620 PMC4205618 · DOI
  86. [91]Jia L, Chopp M, Wang L, Lu X, Szalad A, Zhang Z. Exosomes derived from high-glucose-stimulated Schwann cells promote development of diabetic peripheral neuropathy. FASEB J. 2018:fj201800597R. 10.1096/fj.201800597R. PMC6219828 29932869 · DOI
  87. [92]D’Souza Randall F. Woodhead Jonathan S. T. Zeng Nina Blenkiron Cherie Merry Troy L. Cameron-Smith David Mitchell Cameron. J. Circulatory exosomal miRNA following intense exercise is unrelated to muscle and plasma miRNA abundances American Journal of Physiology-Endocrinology and Metabolism 2018 315 4 E723 E733 10.1152/ajpendo.00138.2018 29969318 · DOI
  88. [93]Moghani-Ghoroghi F Moshkdanian G Sehat M Nematollahi-Mahani SN Ragerdi-Kashani I Pasbakhsh P Melatonin pretreated blastocysts along with calcitonin administration improved implantation by upregulation of heparin binding-epidermal growth factor expression in murine endometrium Cell J 2018 19 599 606 29105394 PMC5672098
  89. [94]Moustakas A Heldin P TGF beta and matrix-regulated epithelial to mesenchymal transition Biochimica Et Biophysica Acta-General Subjects 2014 1840 2621 2634 10.1016/j.bbagen.2014.02.004 24561266 · DOI
  90. [95]Berchem G Noman MZ Bosseler M Paggetti J Baconnais S Le Cam E Nanbakhsh A Moussay E Mami-Chouaib F Janji B Chouaib S Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-β and miR23a transfer Oncoimmunology 2016 5 e1062968 10.1080/2162402X.2015.1062968 27141372 PMC4839360 · DOI
  91. [96]Kobayashi Miharu Salomon Carlos Tapia Jorge Illanes Sebastian E Mitchell Murray D Rice Gregory E Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200 Journal of Translational Medicine 2014 12 1 4 10.1186/1479-5876-12-4 24393345 PMC3896684 · DOI
  92. [97]Tsukerman P Stern-Ginossar N Gur C Glasner A Nachmani D Bauman Y Yamin R Vitenshtein A Stanietsky N Bar-Mag T MiR-10b downregulates the stress-induced cell surface molecule MICB, a critical ligand for Cancer cell recognition by natural killer cells Cancer Res 2012 72 5463 5472 10.1158/0008-5472.CAN-11-2671 22915757 · DOI
  93. [98]Tang B Wu W Wei XW Li Y Ren G Fan WH Activation of glioma cells generates immune tolerant NKT cells J Biol Chem 2014 289 34595 34600 10.1074/jbc.M114.614503 25342742 PMC4263866 · DOI
  94. [99]Yin Y Cai X Chen X Liang HW Zhang YJ Li J Wang ZY Chen XL Zhang W Yokoyama S Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth Cell Res 2014 24 1164 1180 10.1038/cr.2014.121 25223704 PMC4185347 · DOI
  95. [100]Valencia Karmele Luis-Ravelo Diego Bovy Nicolas Antón Iker Martínez-Canarias Susana Zandueta Carolina Ormazábal Cristina Struman Ingrid Tabruyn Sébastien Rebmann Vera De Las Rivas J. Guruceaga Elisabet Bandrés Eva Lecanda Fernando miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization Molecular Oncology 2014 8 3 689 703 10.1016/j.molonc.2014.01.012 24593875 PMC5528646 · DOI
  96. [101]Rana S Malinowska K Zoller M Exosomal tumor MicroRNA modulates Premetastatic organ cells Neoplasia 2013 15 281-+ 10.1593/neo.122010 23479506 PMC3593151 · DOI
  97. [102]Liu Q Yu Z Yuan S Xie W Li C Hu Z Xiang Y Wu N Wu L Bai L Li Y Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer Oncotarget 2017 8 13048 13058 28055956 PMC5355076
  98. [103]Grossi Ilaria Salvi Alessandro Baiocchi Gianluca Portolani Nazario De Petro Giuseppina Functional Role of microRNA-23b-3p in Cancer Biology MicroRNA 2018 7 3 156 166 10.2174/2211536607666180629155025 29962353 · DOI
  99. [104]Chiam K Wang TT Watson DI Mayne GC Irvine TS Bright T Smith L White IA Bowen JM Keefe D Circulating serum Exosomal miRNAs as potential biomarkers for esophageal adenocarcinoma J Gastrointest Surg 2015 19 1208 1215 10.1007/s11605-015-2829-9 25943911 · DOI
  100. [105]Wang M Zhao C Shi H Zhang B Zhang L Zhang X Wang S Wu X Yang T Huang F Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer Br J Cancer 2014 110 1199 1210 10.1038/bjc.2014.14 24473397 PMC3950864 · DOI
  101. [106]Dou R. Nishihara R. Cao Y. Hamada T. Mima K. Masuda A. Masugi Y. Shi Y. Gu M. Li W. da Silva A. Nosho K. Zhang X. Meyerhardt J. A. Giovannucci E. L. Chan A. T. Fuchs C. S. Qian Z. R. Ogino S. MicroRNA let-7, T Cells, and Patient Survival in Colorectal Cancer Cancer Immunology Research 2016 4 11 927 935 10.1158/2326-6066.CIR-16-0112 27737877 PMC5115629 · DOI
  102. [107]Lin XJ Fang JH Yang XJ Zhang C Yuan YF Zheng LM Zhuang SM Hepatocellular carcinoma cell-secreted Exosomal MicroRNA-210 promotes angiogenesis in vitro and in vivo Molecular Therapy-Nucleic Acids 2018 11 243 252 10.1016/j.omtn.2018.02.014 29858059 PMC5992447 · DOI
  103. [108]Zhou X Lu Z Wang T Huang Z Zhu W Miao Y Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: a miRNA expression analysis Gene 2018 673 181 193 10.1016/j.gene.2018.06.037 29913239 · DOI
  104. [109]Chen D Wu X Xia M Wu F Ding J Jiao Y Zhan Q An F Upregulated exosomic miR-23b-3p plays regulatory roles in the progression of pancreatic cancer Oncol Rep 2017 38 2182 2188 10.3892/or.2017.5919 28849236 PMC5652966 · DOI
  105. [110]Bryant R Pawlowski T Catto J Marsden G Vessella R Rhees B Kuslich C Visakorpi T Hamdy F Changes in circulating microRNA levels associated with prostate cancer Br J Cancer 2012 106 768 774 10.1038/bjc.2011.595 22240788 PMC3322952 · DOI
  106. [111]Vlaeminck-Guillem V. Extracellular vesicles in prostate Cancer carcinogenesis, diagnosis, and management. Front Oncol. 2018;8:222. PMC6008571 29951375
  107. [112]Bryzgunova O Zaripov M Skvortsova T Lekchnov E Grigor'eva A Zaporozhchenko I Morozkin E Ryabchikova E Yurchenko Y Voitsitskiy V Laktionov P Comparative study of extracellular vesicles from the urine of healthy individuals and prostate Cancer patients PLoS One 2016 11 e0157566 10.1371/journal.pone.0157566 27305142 PMC4909321 · DOI
  108. [113]Koppers-Lalic D Hackenberg M de Menezes R Misovic B Wachalska M Geldof A Zini N de Reijke T Wurdinger T Vis A Non-invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles Oncotarget 2016 7 22566 22578 10.18632/oncotarget.8124 26992225 PMC5008382 · DOI
  109. [114]Ayub S Kaul D Ayub T Microdissecting the role of microRNAs in the pathogenesis of prostate cancer Cancer Genet 2015 208 289 302 10.1016/j.cancergen.2015.02.010 26004033 · DOI
  110. [115]Li Z Ma Y Wang J Zeng X Li R Kang W Hao X Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients Onco Targets Ther 2016 9 139 148 26770063 PMC4706124
  111. [116]Xu Y Qin S An T Tang Y Huang Y Zheng L MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method Prostate 2017 77 1167 1175 10.1002/pros.23376 28617988 · DOI
  112. [117]Rodríguez M Bajo-Santos C Hessvik N Lorenz S Fromm B Berge V Sandvig K Linē A Llorente A Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes Mol Cancer 2017 16 156 10.1186/s12943-017-0726-4 28982366 PMC5629793 · DOI
  113. [118]Wani S Kaul D Mavuduru R Kakkar N Bhatia A Urinary-exosomal miR-2909: a novel pathognomonic trait of prostate cancer severity J Biotechnol 2017 259 135 139 10.1016/j.jbiotec.2017.07.029 28764970 · DOI
  114. [119]Endzeliņš E Berger A Melne V Bajo-Santos C Soboļevska K Ābols A Rodriguez M Šantare D Rudņickiha A Lietuvietis V Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients BMC Cancer 2017 17 730 10.1186/s12885-017-3737-z 29121858 PMC5679326 · DOI
  115. [120]Bhagirath D Yang T Bucay N Sekhon K Majid S Shahryari V Dahiya R Tanaka Y Saini S microRNA-1246 is an Exosomal biomarker for aggressive prostate Cancer Cancer Res 2018 78 1833 1844 10.1158/0008-5472.CAN-17-2069 29437039 PMC5890910 · DOI
  116. [121]Wang WW Zhong W Yuan JH Yan CC Hu SP Tong YP Mao YB Hu TH Zhang B Song G Involvement of Wnt/beta-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma Oncotarget 2015 6 42276 42289 26474277 PMC4747224
  117. [122]Singh Ramesh Pochampally Radhika Watabe Kounosuke Lu Zhaohui Mo Yin-Yuan Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer Molecular Cancer 2014 13 1 256 10.1186/1476-4598-13-256 25428807 PMC4258287 · DOI
  118. [123]Kosaka N Iguchi H Hagiwara K Yoshioka Y Takeshita F Ochiya T Neutral sphingomyelinase 2 (nSMase2)-dependent Exosomal transfer of Angiogenic MicroRNAs regulate Cancer cell metastasis J Biol Chem 2013 288 10849 10859 10.1074/jbc.M112.446831 23439645 PMC3624465 · DOI
  119. [124]Wen Y Chen R Zhu CH Qiao HM Liu Y Ji H Miao JY Chen LY Liu XX Yang Y MiR-503 suppresses hypoxia-induced proliferation, migration and angiogenesis of endothelial progenitor cells by targeting Apelin Peptides 2018 105 58 65 10.1016/j.peptides.2018.05.008 29800588 · DOI
  120. [125]Vannini I Fanini F Fabbri M Emerging roles of microRNAs in cancer Curr Opin Genet Dev 2018 48 128 133 10.1016/j.gde.2018.01.001 29429825 PMC5986298 · DOI
  121. [126]Tadokoro H Umezu T Ohyashiki K Hirano T Ohyashiki JH Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells J Biol Chem 2013 288 34343 34351 10.1074/jbc.M113.480822 24133215 PMC3843049 · DOI
  122. [127]Gernapudi R Yao Y Zhang YS Wolfson B Roy S Duru N Eades G Yang PX Zhou Q Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer Breast Cancer Res Treat 2015 150 685 695 10.1007/s10549-015-3326-2 25783182 PMC4385483 · DOI
  123. [128]Fong MY Zhou WY Liu L Alontaga AY Chandra M Ashby J Chow A O'Connor STF Li SS Chin AR Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis Nat Cell Biol 2015 17 183-+ 10.1038/ncb3094 25621950 PMC4380143 · DOI · Paper page
  124. [129]Ung Timothy H. Madsen Helen J. Hellwinkel Justin E. Lencioni Alex M. Graner Michael W. Exosome proteomics reveals transcriptional regulator proteins with potential to mediate downstream pathways Cancer Science 2014 105 11 1384 1392 10.1111/cas.12534 25220623 PMC4454399 · DOI
  125. [130]Chen KK Chen Y Chen Z Shi YY He ZM Ding BH Wang CL Yu L miR-134 increases the antitumor effects of cytarabine by targeting Mnks in acute myeloid leukemia cells Oncotargets and Therapy 2018 11 3141 3147 10.2147/OTT.S143465 29872325 PMC5975600 · DOI
  126. [132]Lee HK Finniss S Cazacu S Bucris E Ziv-Av A Xiang CL Bobbitt K Rempel SA Hasselbach L Mikkelsen T Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal Oncotarget 2013 4 346 361 23548312 PMC3712579
  127. [133]Baglio SR, Rooijers K, Koppers-Lalic D, Verweij FJ, Lanzon MP, Zini N, Naaijkens B, Perut F, Niessen HWM, Baldini N, Pegtel DM. Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res Ther. 2015;6. PMC4529699 26129847
  128. [134]Le Minh T.N. Hamar Peter Guo Changying Basar Emre Perdigão-Henriques Ricardo Balaj Leonora Lieberman Judy miR-200–containing extracellular vesicles promote breast cancer cell metastasis Journal of Clinical Investigation 2014 124 12 5109 5128 10.1172/JCI75695 25401471 PMC4348969 · DOI
  129. [135]Cheng L, Wu S, Zhang K, Qing Y, Xu T. A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies. J Ovarian Res. 2017;10:73. PMC5670635 29100532
  130. [136]Yi H Ye J Yang XM Zhang LW Zhang ZG Chen YP High-grade ovarian cancer secreting effective exosomes in tumor angiogenesis Int J Clin Exp Pathol 2015 8 5062 5070 26191200 PMC4503072
  131. [137]Ye SB Li ZL Luo DH Huang BJ Chen YS Zhang XS Cui J Zeng YX Li J Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma Oncotarget 2014 5 5439 5452 10.18632/oncotarget.2118 24978137 PMC4170615 · DOI
  132. [138]Bi L Yang Q Yuan J Miao Q Duan L Li F Wang S MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene Oncol Rep 2016 36 2563 2570 10.3892/or.2016.5055 27571744 · DOI
  133. [139]Dessauge F Cayla X Albar J Fleischer A Ghadiri A Duhamel M Rebollo A Identification of PP1alpha as a caspase-9 regulator in IL-2 deprivation-induced apoptosis J Immunol 2006 177 2441 2451 10.4049/jimmunol.177.4.2441 16888006 · DOI
  134. [140]Zhang S Zhang X Fu X Li W Xing S Yang Y Identification of common differentially-expressed miRNAs in ovarian cancer cells and their exosomes compared with normal ovarian surface epithelial cell cells Oncol Lett 2018 16 2391 2401 30013629 PMC6036573
  135. [141]Nishiyama M Skoultchi A Nakayama K Histone H1 recruitment by CHD8 is essential for suppression of the Wnt-β-catenin signaling pathway Mol Cell Biol 2012 32 501 512 10.1128/MCB.06409-11 22083958 PMC3255766 · DOI
  136. [142]Deng Y Deng H Liu J Han G Malkoski S Liu B Zhao R Wang X Zhang Q Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in breast cancer Mol Carcinog 2012 51 500 507 10.1002/mc.20813 21681822 PMC3177013 · DOI
  137. [143]Challagundla K, Wise P, Neviani P, Chava H, Murtadha M, Xu T, Kennedy R, Ivan C, Zhang X, Vannini I, et al. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst. 2015;107:djv135. PMC4651042 25972604
  138. [144]Cerutti C, Edwards LJ, de Vries HE, Sharrack B, Male DK, Romero IA. MiR-126 and miR-126*regulate shear-resistant firm leukocyte adhesion to human brain endothelium. Sci Rep. 2017;7:45284 PMC5372244 28358058
  139. [145]Farahani Mosavar Rubbi Carlos Liu Luning Slupsky Joseph R. Kalakonda Nagesh CLL Exosomes Modulate the Transcriptome and Behaviour of Recipient Stromal Cells and Are Selectively Enriched in miR-202-3p PLOS ONE 2015 10 10 e0141429 10.1371/journal.pone.0141429 26509439 PMC4625016 · DOI
  140. [146]Umezu T Ohyashiki K Kuroda M Ohyashiki JH Leukemia cell to endothelial cell communication via exosomal miRNAs Oncogene 2013 32 2747 2755 10.1038/onc.2012.295 22797057 · DOI
  141. [147]Paggetti J Haderk F Seiffert M Janji B Distler U Ammerlaan W Kim YJ Adam J Lichter P Solary E Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts Blood 2015 126 1106 1117 10.1182/blood-2014-12-618025 26100252 PMC4560344 · DOI
  142. [149]Isola Allison Eddy Kevinn Chen Suzie Biology, Therapy and Implications of Tumor Exosomes in the Progression of Melanoma Cancers 2016 8 12 110 10.3390/cancers8120110 PMC5187508 27941674 · DOI
  143. [150]Eisenstein A Gonzalez EC Raghunathan R Xu XX Wu MZ McLean EO McGee J Ryu B Alani RM Emerging biomarkers in cutaneous melanoma Molecular Diagnosis & Therapy 2018 22 203 218 10.1007/s40291-018-0318-z 29411301 · DOI
  144. [151]Felicetti F, De Feo A, Coscia C, Puglisi R, Pedini F, Pasquini L, Bellenghi M, Errico MC, Pagani E, Care A. Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma. J Transl Med. 2016;14:56. PMC4765208 26912358
  145. [152]Veija T Sahi H Koljonen V Bohling T Knuutila S Mosakhani N miRNA-34a underexpressed in Merkel cell polyomavirus-negative Merkel cell carcinoma Virchows Arch 2015 466 289 295 10.1007/s00428-014-1700-9 25491743 · DOI

Cited by

Sorted by citations

Authors
Sun, Z., Shi, K., Yang, S., Liu, J., Zhou, Q., Wang, G., Song, J., Li, Z., Zhang, Z., & Yuan, W.
Affiliations
First Affiliated Hospital of Zhengzhou University (CN)
Corresponding author
  • Sun, Zhenqiang
  • Yuan, Weitang
Venue
Molecular Cancer
Published
2018-10-11
Volume
17
Issue
1
Pages
147-147
ISSN
1476-4598 (ISSN-L)
OpenAlex
W2895877601
Cited by
800
References
7
Citations by year
2026: 26 · 2025: 84 · 2024: 139 · 2023: 113 · 2022: 147 · 2021: 159 · 2020: 98 · 2019: 32 · 2018: 1
FWCI
7.14
Type
journal article
Language
en
Open access
Locations
  • Molecular Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81560385)
  • Medical Scientific and Technological Research Project of Henan Province (201702027)
  • Youth Innovation Fund Project of The First Affiliated Hospital of Zhengzhou University (YNQN2017035)
  • China Postdoctoral Science Foundation (2017M610462)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
exosomes, microRNA, extracellular vesicles, ESCRT complex, tumor microenvironment, antitumor immunity, metastasis, angiogenesis, drug resistance, tumor markers, cancer diagnosis and prognosis, intercellular communication, tumor progression
MeSH terms
Cancer-Associated Fibroblasts, Extracellular Matrix, Humans, Neoplasms, Prognosis, Signal Transduction, Biomarkers, RNA Transport, MicroRNAs, Exosomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review